Publications
Through our data expertise and RealLifeData® studies, Tekkare supports research teams in generating robust, transparent, and actionable evidence. These publications illustrate the growing scientific impact of our data and the strength of our collaborations.
Interested in collaborating on a study?
Evidence of our scientific involvement
20
Publications
65
ReaLifeData® Studies
16
Areas Covered
A Growing Scientific Impact
Scientific publications developed with the support of Tekkare and our ReaLifeData® expertise.
Transparency is a cornerstone of meaningful scientific research. Publishing studies supported by high-quality real-world evidence ensures that findings remain reproducible, traceable, and accessible to the scientific community.
RealLifeData® is Tekkare’s structured real-world evidence program, built to conduct standardized studies across multiple therapeutic areas. Each RealLifeData® study follows a rigorous methodology, cleaning, organizing, and transforming complex healthcare data into reliable, analysable outputs.
These publications illustrate how RealLifeData® studies enable transparent, impactful research and strengthen the contributions of our academic and scientific partners.
Our Publications
20List of Publications Scientific articles, posters, and communications developed in collaboration with Tekkare.
2026
Complications and Causes of Readmission Following Midurethral Sling Surgery for Stress Urinary Incontinence in 88,880 Patients
The French Journal of Urology
2025
Vaccination grippe et COVID-19 : qui, quand, comment, en même temps ?
RICAI 2025 - Réunion Interdisciplinaire de Chimiothérapie Anti-Infectieuse
2025
A study based on the French Nationwide Hospitalization Database PMSI to characterize the Osteogenesis Imperfecta population between 2019 and 2023
ASBMR 2025 - The American Society for Bone and Mineral Research
2025
Changes in permanent sterilization practices in France between 2016 and 2022: Comparative analysis of vasectomies and tubal ligations
Sexologies
2025
Avis de la commission de transparence sur BEYONTTRA (population cible)
Haute Autorité de Santé (HAS)
2024
Penile prosthesis for erectile dysfunction in France: A six-year nationwide database analysis
The French Journal of Urology
2024
Complications leading to hospitalisation 12 months after brachytherapy or high-intensity focused ultrasound for localized prostate cancer: French national from the PMSI-MCO data, 2019 and 2020
Clinical and translational Radiation Oncology
PMID: 39381626
Trusted by more than 40 leading life science companies & institutions.
Our platform empowers industry leaders to boost their data governance and drive impactful healthcare innovations.
